Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate and Lidocaine for Myofascial Pain Dysfunction Syndrome
NCT07390851Recruiting
- Sponsor
- Cairo University
- Start
- Nov 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of magnesium sulfate in myofascial pain syndrome (MPS) (2 arms), sponsored by Cairo University. Primary endpoints: Pain reduction at 2 weeks and Muscle activity improvement at 2 weeks. Started Nov 2025; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT07390851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07390851.